GLIROX 250MG & 500MG TABLETS – Ciprofloxacin USP Broad-Spectrum Antibiotic | Pharma Services Group

GLIROX TABLETS are oral antibiotic medicines containing Ciprofloxacin USP, available in 250mg and 500mg strengths. Ciprofloxacin belongs to the fluoroquinolone class of antibacterial medicines and is used to treat certain bacterial infections caused by susceptible organisms. The supplied product images show both GLIROX 250mg and GLIROX 500mg presentations, with 10 tablets per pack. Ciprofloxacin should only be used when a bacterial infection is proven or strongly suspected and when prescribed by an appropriate healthcare professional.

Ciprofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes needed for bacterial growth and replication. Depending on the infection and bacterial susceptibility, ciprofloxacin may be prescribed for certain urinary tract, gastrointestinal, skin and soft-tissue, bone and joint, and other bacterial infections. The appropriate strength—250mg or 500mg—and treatment duration depend on the infection, bacterial susceptibility, kidney function, and individual patient factors.

Ciprofloxacin is a prescription antibiotic and should not be used for viral infections such as the common cold or influenza. Fluoroquinolones can cause serious adverse reactions, including tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects. Therefore, ciprofloxacin should be used only when clinically appropriate and exactly as prescribed.

Purpose

GLIROX is used as an antibacterial medicine for selected infections caused by susceptible bacteria.

Potential indications for ciprofloxacin include certain:

\n
• Urinary tract infections
\n
• Complicated urinary tract infections
\n
• Certain gastrointestinal bacterial infections
\n
• Infectious diarrhea
\n
• Typhoid fever
\n
• Skin and skin-structure infections
\n
• Bone and joint infections
\n
• Chronic bacterial prostatitis
\n
• Certain lower respiratory tract infections
\n
• Other susceptible bacterial infections as determined by a physician
\n

The exact indication depends on the identified or suspected organism and current prescribing guidance.

Key Features

\n
• Active ingredient: Ciprofloxacin USP
\n
• Available in 250mg and 500mg tablets
\n
• Fluoroquinolone antibacterial
\n
• Broad-spectrum antibacterial activity
\n
• Oral tablet formulation
\n
• 10 tablets per pack for each presentation shown
\n
• Designed for treatment of susceptible bacterial infections
\n
• Prescription medicine
\n
• GLIROX is manufactured/marketed under the Glitz Pharma brand shown on the supplied packaging
\n

Benefits

\n
• Treats certain infections caused by susceptible bacteria.
\n
• Available in two commonly used strengths: 250mg and 500mg.
\n
• Oral administration provides a convenient alternative to injectable antibacterial therapy when appropriate.
\n
• Can achieve systemic antibacterial activity after oral administration.
\n
• May be used for a range of susceptible bacterial infections when clinically indicated.
\n

\n

Important: Antibiotics should not be promoted as providing general health benefits. Ciprofloxacin provides benefit only when it is appropriate for the specific bacterial infection being treated.

\n

Pros

\n
• Well-established fluoroquinolone antibiotic.
\n
• Available in 250mg and 500mg strengths.
\n
• Broad antibacterial spectrum.
\n
• Convenient oral tablet dosage form.
\n
• Useful against a range of susceptible bacterial organisms.
\n

Cons

\n
• Prescription-only antibiotic requiring appropriate medical assessment.
\n
• Can cause gastrointestinal adverse effects such as nausea and diarrhea.
\n
• May cause serious or potentially persistent adverse reactions involving tendons, nerves, muscles, or the central nervous system.
\n
• Has clinically important drug and food/mineral interactions.
\n
• Not effective against viral infections.
\n
• Antibiotic resistance can develop when used unnecessarily or incorrectly.
\n

Active Ingredient

Ciprofloxacin USP

Available Strengths

\n
• GLIROX 250MG TABLET
\n
• GLIROX 500MG TABLET
\n

Dosage Form

Film-Coated Oral Tablet

Pack Size

10 Tablets per Pack

Drug Class

Fluoroquinolone Antibacterial / Broad-Spectrum Antibiotic

Manufacturer

Glitz Pharma
Based on the manufacturer/brand information visible on the supplied packaging.

Dosage & Administration

The appropriate ciprofloxacin dose depends on the type and severity of infection, susceptibility of the causative organism, kidney function, and other patient-specific factors. Do not select 250mg or 500mg yourself.

For adults, prescribing information includes examples such as 250–500mg every 12 hours for certain urinary tract infections, while other infections may require different strengths and durations. Renal impairment may require adjustment of the dosing interval or regimen.

Ciprofloxacin should be taken exactly as prescribed. Patients should maintain adequate fluid intake unless otherwise instructed by their healthcare professional.

Important Administration Information

Ciprofloxacin absorption can be reduced by products containing magnesium, aluminum, calcium, iron, or zinc, as well as certain antacids and sucralfate. These products generally need to be separated from ciprofloxacin administration according to prescribing instructions.

Storage Instructions

\n
• Store at room temperature in a dry place.
\n
• Protect from excessive heat and moisture.
\n
• Keep tablets in their original packaging.
\n
• Keep away from direct sunlight.
\n
• Keep out of reach of children.
\n
• Do not use after the expiry date.
\n

Precautions & Warnings

\n
• Use only when prescribed for an appropriate bacterial infection.
\n
• Do not use for viral illnesses such as common cold or influenza.
\n
• Ciprofloxacin is contraindicated in patients with known hypersensitivity to ciprofloxacin or other quinolones.
\n
• Ciprofloxacin must not be taken with tizanidine because of a clinically significant interaction.
\n
• Fluoroquinolones have been associated with tendinitis and tendon rupture. The risk is higher in older adults, people taking corticosteroids, and certain transplant recipients.
\n
• Peripheral neuropathy and central nervous system effects can occur and may potentially be serious.
\n
• Avoid unnecessary exposure to excessive sunlight/UV radiation because photosensitivity reactions may occur.
\n
• Ciprofloxacin may prolong the QT interval and requires caution in susceptible patients or when combined with other QT-prolonging medicines.
\n
• Contact a healthcare professional if severe or persistent diarrhea develops during or after treatment.
\n
• People with kidney impairment may require dose adjustment.
\n
• Seek medical attention promptly for tendon pain/swelling, numbness or tingling, severe weakness, serious rash, breathing difficulty, or other severe reactions.
\n
• Complete the prescribed treatment exactly as directed unless a healthcare professional tells you to stop.
\n

Product Specifications